Innovation & Research
Tuesday, October 6, 2020
With the help of an influential professor, Blake Dubé’s (ENGR ’17) portable oxygen company won several innovation competitions at Pitt and has now spun into a new market: helping pets.
Monday, October 5, 2020
In some patients with HIV who take medication, the virus still shows up in their blood. A study led by John Mellors has found “repliclones”—large clones of HIV-infected cells that produce infectious virus particles—are to blame.
Monday, October 5, 2020
A team of undergraduate students and faculty members is using techniques from engineering to provide a picture of how well students are complying with safety standards on the Pittsburgh campus.
Wednesday, September 30, 2020
A team led by Madhu Choudhary has joined a national trial testing therapies to keep COVID-19 patients out of the hospital. Funded through Operation Warp Speed, it is one of a handful of new trials at Pitt.
Tuesday, September 29, 2020
On World Heart Day, learn about how radiology’s Darshit Thakrar creates 3D models of children’s hearts and other organs to help surgeons better picture their procedures.
Tuesday, September 29, 2020
A new study co-led by Ivet Bahar uses computational modeling to address a mystery first raised in March: Why do some people with COVID-19 develop severe inflammation?
Monday, September 28, 2020
Debasish Sinha will work with Astellas Pharma Inc. in a new research collaboration to address dry age-related macular degeneration—a common cause of vision loss.
Friday, September 25, 2020
New Pitt research published in the Journal of the American Medical Association has found that occupational and physical therapy after hospitalization for pneumonia is associated with a decreased risk of readmission and death in the month following discharge.
Thursday, September 24, 2020
Sara Baumann (GSPH ’19) and Jessica Burke have created a new form of public health research called Collaborative Filmmaking. The six-step process engages its participants to create a detailed, multimedia form of study rarely seen in the field.
Wednesday, September 16, 2020
Pitt Public Health scientists found that a drop in the supply of carfentanil, a potent drug, was likely the reason behind 2018's decrease in overdose deaths, rather than U.S. efforts to curb them.